PPIAL4E (Gene)

Synonyms:COAS2, ENTREZ:730262, HGNC:33997, MIM:608608, NM_001144032, NP_001137504, PPIAL4E, PPIAL4F, peptidylprolyl isomerase A like 4E
Id:ENSG00000271567
Entrez:730262
Description:peptidylprolyl isomerase A like 4E
Predicted to enable cyclosporin A binding activity and peptidyl-prolyl cis-trans isomerase activity. Predicted to be involved in protein folding and protein peptidyl-prolyl isomerization. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View PPIAL4E's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with PPIAL4E.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using PPIAL4E.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for PPIAL4E.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PPIAL4E.

Results found

Linked to

 

Label

Description

 

Gene Set

A Gene Set from LINCS

Gene Set

A Gene Set from LINCS

Gene Set

A Gene Set from LINCS

Collection

Associations for PPIAL4E_associations

Collection

TargetPage Collection: (TID:18215; NCBI_GENE_ID:, FILE=tcrd_target_18215.json)




  • Collection

    Associations for PPIAL4E_associations


  • Collection

    TargetPage Collection: (TID:18215; NCBI_GENE_ID:, FILE=tcrd_target_18215.json)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.